Coverage of hospital-based cataract surgery and barriers to the uptake of surgery among cataract blind persons in nigeria: the Nigeria National Blindness and Visual Impairment Survey

Ophthalmic Epidemiology
Tafida AbubakarAbdullahi U Imam

Abstract

To determine cataract surgical coverage, and barriers to modern cataract surgery in Nigeria. Multistage stratified cluster random sampling was used to identify a nationally representative sample of 15,027 persons aged 40+ years. All underwent visual acuity testing, frequency doubling technology visual field testing, autorefraction, and measurement of best corrected vision if <6/12 in one or both eyes. An ophthalmologist examined the anterior segment and fundus through an undilated pupil for all participants. Participants were examined by a second ophthalmologist using a slit lamp and dilated fundus examination using a 90 diopter condensing lens if vision was <6/12 in one or both eyes, there were optic disc changes suggestive of glaucoma, and 1 in 7 participants regardless of findings. All those who had undergone cataract surgery were asked where and when this had taken place. Individuals who were severely visually impaired or blind from unoperated cataract were asked to explain why they had not undergone surgery. A total of 13,591 participants were examined (response rate 89.9%). Prevalence of cataract surgery was 1.6% (95% confidence interval 1.4-1.8), significantly higher among those aged ≥70 years. Cataract surgical coverage...Continue Reading

References

Nov 1, 1988·The British Journal of Ophthalmology·V Mehra, D C Minassian
Feb 1, 2002·Ophthalmic Epidemiology·B ThyleforsUNKNOWN WHO Cataract Grading Group
Feb 28, 2002·The British Journal of Ophthalmology·C L MoserJ Mas
Sep 20, 2005·The British Journal of Ophthalmology·S LewallenP Courtright
Jun 13, 2006·Clinical & Experimental Ophthalmology·Jambi N GarapCarmel Williams
Jul 21, 2006·Ophthalmic Epidemiology·Maria Eugenia NanoHans Limburg
Dec 5, 2006·Ophthalmology·Wanjiku MathengeAllen Foster
Dec 21, 2006·PLoS Medicine·Jeremiah NgondiPaul M Emerson
Dec 22, 2006·Clinical & Experimental Ophthalmology·Garry BrianThomas Naduvilath
Dec 22, 2006·Clinical & Experimental Ophthalmology·Jambi N GarapCarmel Williams
Mar 6, 2007·Ophthalmology·Fernando BeltranenaHans Limburg
Mar 29, 2007·The British Journal of Ophthalmology·Joseph Enyegue Oye, Hannah Kuper
Oct 24, 2007·Ophthalmology·Min WuHannah Kuper
Oct 29, 2008·Clinical & Experimental Ophthalmology·Paul A AthanasiovThan Aung
Dec 10, 2008·Ophthalmic Epidemiology·Muhammad Mansur Rabiu, Nasiru Muhammed
Apr 24, 2009·Investigative Ophthalmology & Visual Science·Mohammed M AbdullUNKNOWN Nigeria National Blindness and Visual Impairment Study Group
May 2, 2009·American Journal of Ophthalmology·Solange R SalomãoLeon B Ellwein
Aug 21, 2009·The British Journal of Ophthalmology·A SherchanK L Bassett
Nov 3, 2009·Clinical & Experimental Ophthalmology·Paul A AthanasiovRobert J Casson
Dec 10, 2009·Ophthalmic Epidemiology·Gudlavalleti V S MurthyLeon B Ellwein
Feb 6, 2010·Ophthalmic Epidemiology·Celestin HabiyakireSusan Lewallen
Mar 23, 2010·Ophthalmic Epidemiology·Yuddha D SapkotaHim K Adhikari
Sep 28, 2010·Ophthalmic Epidemiology·Clare E GilbertA Tafida

❮ Previous
Next ❯

Citations

Sep 7, 2012·PLoS Neglected Tropical Diseases·Saul N RajakMatthew J Burton
Sep 5, 2012·Indian Journal of Ophthalmology·Gudlavalleti V S MurthyHira B Pant
Sep 5, 2012·Indian Journal of Ophthalmology·Karl Blanchet, Daksha Patel
Feb 9, 2010·Annals of African Medicine·Abdulkabir Ayansiji AyanniyiMichael Kehinde Edward
Dec 15, 2015·Ophthalmic Epidemiology·Paula Anne Newman-CaseyAlan L Robin
Feb 27, 2014·Cost Effectiveness and Resource Allocation : C/E·Ulla K GriffithsClare Gilbert
Sep 24, 2015·Ophthalmic Epidemiology·A TafidaUNKNOWN Nigeria National Survey of Blindness and Visual Impairment Study Group
Mar 1, 2012·Ophthalmic Epidemiology·Emily Y Chew
Oct 8, 2013·Ophthalmic Epidemiology·Ulla Kou GriffithsMusonda Mumba
Nov 29, 2017·Ophthalmic Epidemiology·Nazaradden IbrahimClare E Gilbert
Feb 24, 2017·The British Journal of Ophthalmology·Jacqueline RamkeClare E Gilbert
Jul 6, 2014·The British Journal of Ophthalmology·Karl BlanchetDon de Savigny
Apr 4, 2019·Current Gerontology and Geriatrics Research·Nilanga NishadA R Wickramasinghe
Nov 10, 2017·The Cochrane Database of Systematic Reviews·Jacqueline RamkePeter Tugwell
Nov 26, 2019·Therapeutic Advances in Ophthalmology·Mary O UgalahiLinda O Ugalahi
Aug 8, 2021·The British Journal of Ophthalmology·Olusola Oluyinka OlawoyeNathan Congdon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.